OÜ Milvesta

Active Registry code 10748981 OÜ Keila-Joa alevik Registered 5 Apr 2001
Compare

OÜ Milvesta is a OÜ based in Keila-Joa alevik, registry code 10748981, status: active. Main activity: Manufacture of pharmaceutical preparations. Its annual report for 2025 shows revenue of €1 266 and 0 employees.

Revenue
1 266 €
↓ 1.3% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Revenue · 2025 1 266 €
    industry median 48 003 € · companies in the industry: 19
  • Net profit margin · 2025 53.4 %
    industry median 9.8 % · companies in the industry: 15

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2016 – 2025
Revenue, € 2025: 1 266 € · −1.3% vs 2024 · industry median 48 003 € · above 25% of the industry
010 00020 00030 00040 00050 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 2 075 € Industry median: 28 809 €20192020 Company: 1 953 € Industry median: 25 207 €20202021 Company: 1 985 € Industry median: 11 877 €20212022 Company: 2 119 € Industry median: 4 897 €20222023 Company: 1 010 € Industry median: 3 851 €20232024 Company: 1 283 € Industry median: 25 284 €20242025 Company: 1 266 € Industry median: 48 003 €2025010 00020 00030 00040 00050 0002018 Company: — Industry median: —2019 Company: 2 075 € Industry median: 28 809 €20192020 Company: 1 953 € Industry median: 25 207 €2021 Company: 1 985 € Industry median: 11 877 €20212022 Company: 2 119 € Industry median: 4 897 €2023 Company: 1 010 € Industry median: 3 851 €20232024 Company: 1 283 € Industry median: 25 284 €2025 Company: 1 266 € Industry median: 48 003 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 676 € · +337.2% vs 2024 · industry median 676 € · above 50% of the industry
-1 00001 0002 0003 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -211 € Industry median: 2 812 €20192020 Company: 97 € Industry median: 97 €20202021 Company: -30 € Industry median: 0 €20212022 Company: -756 € Industry median: 0 €20222023 Company: 368 € Industry median: 0 €20232024 Company: -285 € Industry median: 0 €20242025 Company: 676 € Industry median: 676 €2025-1 00001 0002 0003 0002018 Company: — Industry median: —2019 Company: -211 € Industry median: 2 812 €20192020 Company: 97 € Industry median: 97 €2021 Company: -30 € Industry median: 0 €20212022 Company: -756 € Industry median: 0 €2023 Company: 368 € Industry median: 0 €20232024 Company: -285 € Industry median: 0 €2025 Company: 676 € Industry median: 676 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 53.4 % · +75.6 pp vs the year before · industry median 9.8 % · above 92% of the industry
-40-2002040602016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -10.2 % Industry median: 10.2 %20192020 Company: 5.0 % Industry median: 7.1 %20202021 Company: -1.5 % Industry median: 1.4 %20212022 Company: -35.7 % Industry median: -1.9 %20222023 Company: 36.4 % Industry median: 4.4 %20232024 Company: -22.2 % Industry median: 1.2 %20242025 Company: 53.4 % Industry median: 9.8 %2025-40-2002040602018 Company: — Industry median: —2019 Company: -10.2 % Industry median: 10.2 %20192020 Company: 5.0 % Industry median: 7.1 %2021 Company: -1.5 % Industry median: 1.4 %20212022 Company: -35.7 % Industry median: -1.9 %2023 Company: 36.4 % Industry median: 4.4 %20232024 Company: -22.2 % Industry median: 1.2 %2025 Company: 53.4 % Industry median: 9.8 %2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 3 140 € · +35.9% vs 2024
01 0002 0003 0004 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 3 490 €20192020 Company: 2 931 €20202021 Company: 2 881 €20212022 Company: 2 123 €20222023 Company: 2 713 €20232024 Company: 2 310 €20242025 Company: 3 140 €202501 0002 0003 0004 0002018 Company: —2019 Company: 3 490 €20192020 Company: 2 931 €2021 Company: 2 881 €20212022 Company: 2 123 €2023 Company: 2 713 €20232024 Company: 2 310 €2025 Company: 3 140 €2025
Equity, € 2025: 2 883 € · +30.6% vs 2024
01 0002 0003 0004 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 3 181 €20192020 Company: 2 909 €20202021 Company: 2 879 €20212022 Company: 2 123 €20222023 Company: 2 491 €20232024 Company: 2 207 €20242025 Company: 2 883 €202501 0002 0003 0004 0002018 Company: —2019 Company: 3 181 €20192020 Company: 2 909 €2021 Company: 2 879 €20212022 Company: 2 123 €2023 Company: 2 491 €20232024 Company: 2 207 €2025 Company: 2 883 €2025
Employees 2025: 0 · industry median 28 · above 2% of the industry
0102030402016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: —20182019 Company: 0 Industry median: 3420192020 Company: 0 Industry median: 32.520202021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —20222023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 3220242025 Company: 0 Industry median: 2820250102030402018 Company: 0 Industry median: —2019 Company: 0 Industry median: 3420192020 Company: 0 Industry median: 32.52021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —2023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 322025 Company: 0 Industry median: 282025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 1 266 676 0 3 140 2 883 0
2024 1 283 -285 0 2 310 2 207 0
2023 1 010 368 0 2 713 2 491 0
2022 2 119 -756 0 2 123 2 123 0
2021 1 985 -30 0 2 881 2 879 0
2020 1 953 97 0 2 931 2 909 0
2019 2 075 -211 0 3 490 3 181 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0
2014 — — — — — 0
2013 — — — — — 0
2012 — — — — — 0
2011 — — — — — 0
2010 — — — — — 0
2009 — — — — — 0
2008 — — — — — 0
2007 — — — — — 0
2006 — — — — — 0
2005 — — — — — 0
2004 — — — — — 1
2003 — — — — — 2
2002 — — — — — 2
2001 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
53.4 %
Net profit / revenue
Return on equity (ROE)
23.4 %
Net profit / equity
Return on assets (ROA)
21.5 %
Net profit / assets
Equity ratio
91.8 %
Equity / assets
Debt ratio
8.2 %
Liabilities / assets
Current ratio
12.22
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 25 Apr 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 4 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 17 May 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 4 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 16 May 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 18 Jun 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 27 May 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 21201Manufacture of pharmaceutical preparations Main
Rulings
Number, date Title Deadline State Document
Ä 10055017 / 8
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 10055017 / 7
17 Jan 2018
Amendment entry In force
17 Jan 2018
PDF
Ä 10055017 / 6
5 Dec 2017
Amendment entry In force
5 Dec 2017
PDF
Ä 10055017 / 5
7 Nov 2017
Amendment entry In force
7 Nov 2017
PDF
Ä 10055017 / 4
22 Jul 2016
Amendment under Commercial Code § 525 (2) In force
22 Jul 2016
PDF
Ä 10055017 / M3
20 Jul 2016
Procedural ruling In force
20 Jul 2016
PDF
Ä 10055017 / 3
28 Dec 2011
Amendment entry In force
28 Dec 2011
PDF
Ä 10055017 / M2
8 Dec 2011
Ruling to eliminate deficiencies 28 Feb 2012 In force
8 Dec 2011
PDF
Ä 55017 / 2
3 Dec 2008
Deletion of activities from the registry card In force
4 Dec 2008
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data